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Abstract
Exercise stress testing has been widely undertaken for the diagnosis of heart diseases. The accurate assessment of clinical 
conditions can be conducted by comparing the findings obtained from the results of stress echocardiography with the changes 
in the blood/heart rate and electrocardiograms. Numerous overseas studies have reported the utility of stress echocardiography 
in diagnosing myocardial ischemia; in Japan, the use of this modality for this purpose was included in the national health 
insurance reimbursable list in 2012. Nevertheless, stress echocardiography is far from being a widespread practice in Japan. 
This might be due to insufficient equipment (e.g., ergometers, space for test implementation) at each medical institution, 
shortage of technicians and sonographers who are well experienced and who are responsible for obtaining images during 
stress testing. The other possible reasons include the limited evidence available in Japan and the lack of a standardized test-
ing protocol. Further dissemination of the practice of exercise stress echocardiography in this country is deemed necessary 
to establish satisfactory evidence for the use of stress echocardiography in the Japanese population. To this end, efforts are 
underway to develop a standardized protocol and report format to be adopted throughout Japan. We here present a guideline 
created by the Guideline Development Committee of the Japanese Society of Echocardiography that describes safe and 
effective stress echocardiography protocols and report formats. The readers are encouraged to perform exercise stress echo-
cardiography using the proposed template for consensus document and report attached to this guideline.
Keywords Peak oxygen uptake · METS (metabolic equivalents) · Ischemic heart disease · Valvular heart disease · 
Cardiomyopathy · Dobutamine · Stress echocardiography
Introduction
During exercise to sustain the increased metabolic demand 
of the tissues, increased oxygen and nutrient delivery 
are accomplished by increasing cardiac output (CO) and 
blood flow to the microvascular surface area, in addition to 
increased  O2 extraction in the active muscles (heart, respira-
tory, abdominal and skeletal muscles).
Furthermore exercise-associated tachycardia and blood 
pressure elevation lead to valvular regurgitation and 
increased myocardial oxygen consumption. Examining car-
diac function during exercise as well as at rest is thus impor-
tant for selecting suitable therapy for heart disease. Exercise 
stress testing has been widely undertaken for the diagnosis 
of heart diseases [1, 2]. In the circumstances where exercise 
stress cannot be performed, detailed evaluations under drug 
stimulation have been carried out to make an assessment of 
cardiac reserve. The accurate assessment of clinical condi-
tions can be conducted by comparing the findings obtained 
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from the results of stress echocardiography with the changes 
in the blood/heart rate and electrocardiograms (ECGs). 
Numerous overseas studies have reported the utility of stress 
echocardiography in diagnosing myocardial ischemia; [3] 
in Japan, and the use of this modality for this purpose was 
included in the national health insurance reimbursable list 
in 2012.
Nevertheless, stress echocardiography is far from being 
a widespread practice in Japan. This might be due to insuf-
ficient equipment (e.g., ergometers, space for test implemen-
tation) at each medical institution, shortage of technicians 
and sonographers who are well experienced and who are 
responsible for obtaining images during stress testing. The 
other possible reasons include the limited evidence available 
in Japan and the lack of a standardized testing protocol. Fur-
ther dissemination of the practice of exercise test echocar-
diography in this country is deemed necessary to establish 
satisfactory evidence for the use of stress echocardiography 
in the Japanese population. To this end, efforts are under-
way to develop a standardized protocol and report format to 
be adopted throughout Japan. We here present a guideline 
created by the Guideline Development Committee of the 
Japanese Society of Echocardiography that describes safe 
and effective stress echocardiography protocols and report 
formats.
Overview
Stressing methods for stress echocardiography
Stress echocardiography is mainly conducted during exercise 
or under drug stimulation. For the pharmacological stress 
testing, adenosine was once administered. At present, dobu-
tamine is the only drug used for this purpose (dobutamine 
stress testing is described below for reference purposes). The 
other stressing methods include pacing, hyperventilation, 
and the use of a cold pressor (Table 1); they are employed 
only under special circumstances.
Exercise stress testing methods
Exercise stress testing can be performed with isometric 
(e.g., handgrip) or isotonic (e.g., treadmill, ergometer) exer-
cise. To evaluate the cardiac pumping capacity, we need to 
increase CO by raising oxygen consumption in the periph-
eral tissues. When we intend to induce myocardial ischemia 
by elevating myocardial oxygen consumption, myocardial 
oxygen demand needs to be raised. Myocardial oxygen con-
sumption largely depends on left ventricular (LV) wall stress 
and heart rate rather than CO; therefore, to evoke myocardial 
ischemia, it is necessary to increase LV wall stress and heart 
rate, i.e., to achieve higher blood pressure and heart rate via 
exercise. While the cardiac pumping capacity is assessed, it 
is essential to raise CO.
Generally, an isometric exercise is characterized by 
smaller increases in heart rate, compared with the magnitude 
of increases in systolic blood pressure, at higher exercise 
intensity. In an isotonic exercise, greater exercise intensity 
is associated with greater CO; both blood pressure and heart 
rate typically show a linear increase in proportion to exercise 
intensity. In principle, venous return is increased, resulting 
chiefly in ventricular expansion. This venous return increase 
is more conspicuous when the subject is in a recumbent 
position than on standing.
Isometric exercise stress, which is associated with greater 
blood pressure elevation than with isotonic stress, may allow 
improved detection rates for wall motion abnormalities since 
such abnormalities are more readily visualized in the pres-
ence of elevated LV wall stress, as well as ischemia, which 
can be induced with isometric exercise by increasing myo-
cardial oxygen demand.
To evaluate pumping ability of the heart, an increase in 
stroke volume (SV) should be monitored. In the exercise 
Table 1  Stressing methods for stress echocardiography
Exercise Pharmacological Others
Stressing methods Treadmill Dobutamine Pacing
Ergometer Dipyridamole Hyperventilation/cold pressor
Handgrip Adenosine Leg raising
Type of stress Physiological Nonphysiological Nonphysiological
Heart rates Increased Increased Vary depending on stress
Blood pressures Increased Not necessarily increased Vary depending on stress
Image quality Can be unassessable Adequate for assessment in many cases Adequate for assessment in many cases
Venous route Not needed Needed Needed/not needed
Other In patients capable of performing 
exercise, objective exercise tolerance 
and relationship to symptoms can be 
assessed
Cardiac stress can be imposed in the 
patients incapable of performing 
exercise
Leg raising is a simple technique to 
increase preload
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stress testing for aortic stenosis (AS), elevation in pressure 
gradient and change in valve area resulting from increased 
SV are examined; therefore, the type of stress that raises SV 
(e.g., stress on recumbent exercise) is more desirable than 
the type that merely raises heart rate (e.g., pacing).
On the other hand, in the stress testing for mitral stenosis 
(MS), where the diastolic period is markedly shortened with 
increased heart rate, the magnitude of the effect of shortened 
diastolic period exceeds that of stress from CO increase, 
resulting in a greater left atrioventricular pressure gradient. 
In other words, the stress testing for MS is for the assess-
ment of cardiac capacity under the conditions of elevated 
heart rate.
Mitral regurgitation (MR) can have an organic or func-
tional cause, and how imposed stress will interact with such 
causes is unpredictable. In this context, it may be best to 
apply types of stress closest to those encountered in daily 
activities (e.g., stress that raises cardiac output) in evaluating 
patients’ symptoms.
In many cases, stress testing for myocardial disease is 
conducted to assess the contractile reserve of the myocar-
dium itself. Pharmacological stress testing with low-dose 
catecholamines is therefore desirable.
Physiology of exercise stress
During exercise, depending on its intensity, the volume of 
oxygen uptake (VO2) increases. The VO2 at the time when 
the target heart rate is reached in symptom-limited stress 
testing is called the peak VO2. The highest VO2 achieved 
with exercise of increasing intensity (plateau VO2) is called 
the maximal VO2.
Peak VO2 is determined by the maximum oxygen trans-
port capability and the maximum oxygen utilization capa-
bility during exercise. The maximum oxygen transport 
capability depends on the vasodilatory ability and the abil-
ity to efficiently perfuse the skeletal muscles with blood, in 
addition to CO reserve. The maximum oxygen utilization 
capability relies on the ability of the active muscles to take 
up oxygen effectively. Possible mechanisms for a decrease 
in peak VO2 in patients with heart failure thus include: 
lower CO, lower blood pressure, reduced vasodilation due 
to endothelial dysfunction, decreased muscle volume due 
to restriction of physical activity and disuse atrophy, skel-
etal mitochondrial change due to chronic hypoperfusion, 
and decreased activity of enzymes, such as the enzymes of 
oxidative phosphorylation, which are involved in muscular 
energy metabolism.
Stress testing should be performed using a method suit-
able for the purpose of testing, selected based on predicted 
changes in variables in response to a given stress. In select-
ing the testing method, it is imperative to give top priority 
to the safety of the patient, taking into consideration his/
her condition. For the elderly, cycle ergometer exercise is 
recommended as falls are unlikely, rather than a treadmill 
exercise, which in the elderly is associated with a risk of 
falls and possibly excessive workload in terms of oxygen 
consumption.
Ergometer and treadmill exercise tests achieve similar 
heart rate and ventilation at the highest exercise intensity, 
but the peak VO2 at that point is generally 5–11% higher 
with treadmill exercise [4]. In other words, the peak VO2 
determined using ergometer exercise is lower than that 
obtained from the results of a treadmill. These two stress-
ing methods also differ in terms of the effect of the subject’s 
body weight on VO2 per unit weight. With treadmill exer-
cise, workload is produced by walking; that is, the patient 
does work by shifting his/her weight. The workload is thus 
expressed by ‘work rate’, i.e., body weight × walking veloc-
ity. The heavier the subject, the greater is the workload. 
When the incline and walking speed are changed, the VO2 
per weight (METS; metabolic equivalents) changes, while 
the relationship between the workload and VO2 remains the 
same regardless of subject’s body weight. Meanwhile, using 
cycle ergometer exercise, where the subject pedals in a sit-
ting position, the relationship between the workload and VO2 
per body weight varies depending on the body weight: VO2 
per weight becomes smaller at greater weights [5].
When treadmill exercise is used for echocardiography, 
the patient moves to the testing bed and receives echocar-
diography after finishing the exercise; the data obtained are 
thus post-exercise echocardiograms. With supine ergometer 
exercise, stress testing echocardiograms can be acquired dur-
ing exercise, a distinct feature of this test.
Objectives of exercise stress echocardiography
Ischemic heart disease1
1. The diagnosis of coronary artery disease
  Patients in whom echocardiographic assessment is 
less reliable when detecting ischemia: in those admin-
istered with digoxin, those with pre-excitation (Wolff–
Parkinson–White) syndrome and those with complete 
left bundle-branch block.
1 Statement on exercise echocardiography for ischemic heart disease 
from the American Heart Association (AHA) Guideline.
 The 2003 AHA guideline [6] includes a new Class I recommenda-
tion: Exercise echocardiography for diagnosis of myocardial ischemia 
in intermediate-risk patients on digoxin, with LV hypertrophy, or 
with more than 1 mm ST depression at rest on the baseline electro-
cardiographic assessment; and patients with Wolff–Parkinson–White 
syndrome or a conduction disturbance such as left bundle-branch 
block. Namely, exercise echocardiography combined with wall 
motion assessment should be performed in patients showing abnor-
mal waveforms on the 12-lead electrocardiogram at rest.
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  The meta-analysis results are available for diagnos-
tic accuracy of exercise echocardiography for identify-
ing coronary artery disease [7–9] The sensitivity and 
specificity were reported to be 87 and 72%, respectively, 
in the meta-analysis by de Jong et al. [8] and 82.7 and 
84.0%, respectively, by Heijenbrok-Kal et al. [9]. Table 2 
summarizes the findings on the diagnostic accuracy of 
different stress echocardiographic modalities [9].
2. Prognosis and risk assessment.
  In several studies published to date on the use of 
exercise stress echocardiography for the assessment of 
prognosis and risk, this modality has been reported to be 
useful in assessing numerous diseases. Negative results 
on exercise stress echocardiography predict favorable 
patient outcomes [10]. Exercise stress testing has also 
been found to be of prognostic value for women; [11] 
the elderly; [12] patients with diabetes mellitus [13], 
angina pectoris [14], or acute myocardial infarction; 
[15–17] and in patients who have undergone coronary 
artery bypass grafting (CABG) [18]. Monitoring such 
subpopulation for abnormal wall motion with exercise 
stress echocardiography is useful for predicting cardio-
vascular events.
3. Preoperative evaluation for cardiovascular surgery and 
other major surgery.
  Stress echocardiography has been reported to be use-
ful for preoperative risk assessment prior to cardiovas-
cular surgery [19, 20] and other major surgery [21, 22].
4. Assessment of residual myocardial ischemia after a 
revascularization procedure such as percutaneous coro-
nary intervention and CABG.
  Exercise stress echocardiography has been reported to 
be useful in evaluating residual myocardial ischemia in 
patients following revascularization such as percutane-
ous coronary intervention [23] and CABG [24].
5. Diagnosis of the location of myocardial ischemia.
  In identifying the location of myocardial ischemia, 
the utility of exercise stress echocardiography and coro-
nary arteriography has been compared, and it has been 
concluded that the former is very useful, with a high 
consistency shown between myocardial ischemia loca-
tion and coronary lesion [25].
6. Assessment of myocardial viability.
  Regarding myocardial viability assessment, several 
studies found that low-dose dobutamine stress testing 
was useful [26]. Some studies reported that myocardial 
viability can be evaluated based on wall motion assess-
ment performed during low-level ergometer exercise 
[27, 28].
7. Relationship with chest symptoms on exertion.
  Exercise echocardiography is useful for the diagnosis 
of patients with dyspnea on exertion and can predict 
outcomes of patients with dyspnea [29].
Cardiomyopathy
1. Dilated cardiomyopathy Evaluation of contractile 
reserve, exercise-induced dyssynchrony, MR, and pul-
monary hypertension (PH).2
2. Hypertrophic cardiomyopathy Evaluation of exercise-
induced LV outflow tract (LVOT) obstruction, MR, PH,2 
and regional wall motion.
3. Relationship with symptoms on exertion.
Valvular heart disease
1. MR Assessment of exercise-induced changes in MR and 
PH.2 Prediction of postoperative LV function.
2. MS Assessment of left atrioventricular pressure gradi-
ent in patients who show findings on resting echocar-
diograms that are disproportionate to symptoms; and 
assessment of PH.
3. AS Risk assessment for asymptomatic, severe AS.
4. Aortic regurgitation (AR) Assessment of contractile 
reserve and prediction of decline in cardiac function 
after aortic valve replacement.
5. Relationship to symptoms on exertion.
Pulmonary hypertension
1. PH Diagnosis of exercise-induced PH,2 prediction of 
prognosis, and assessment of treatment effect.
2. Relationship to symptoms on exertion.
Ensuring safety in exercise stress echocardiography
The safety of exercise stress echocardiography has been 
established. The incidence rate of serious complications 
(e.g., serious arrhythmias, myocardial infarction) has been 
Table 2  Diagnostic accuracy of various stress echocardiographic 
modalities
Number 
of stud-
ies
Sensitivity (%) 
(95% confidence 
interval)
Specificity (%) (95% 
confidence interval)
Exercise stress 55 82.7 (80.2–85.2) 84.0 (80.4–87.6)
Adenosine 11 79.2 (72.1–86.3) 91.5 (87.3–95.7)
Dipyridamole 58 71.9 (68.6–75.2) 94.6 (92.9–96.3)
Dobutamine 102 81.0 (79.1–82.9) 84.1 (82.0–86.1)
2 As the tricuspid regurgitation pressure gradient increases during 
exercise with age, even in healthy individuals, caution is required for 
the interpretation of the results of evaluation, especially in the elderly 
[30].
109Journal of Echocardiography (2018) 16:105–129 
1 3
reported to be 0.04% during stress exercise testing, 0.01% 
after stress exercise testing, and ≤ 0.2% for overall complica-
tions [7]. Particular attention should be paid to ensure the 
safety in patients who are unable to perform exercise stress 
testing for physical reasons, since they are at higher risk 
of developing serious complications. For such patients, we 
recommend that the testing is performed in a sufficiently 
spacious room with the following equipment readily avail-
able: an emergency cart with emergency drugs and airway 
management devices, exercise stress monitoring system 
(automated sphygmomanometer, 12-lead ECG monitor), 
defibrillator, and oxygen tanks (Fig. 1).
Contraindications for exercise stress 
echocardiography
To perform exercise stress testing safely and acquire the data 
useful for diagnosis, it is important to predetermine if the 
patient is eligible for stress testing. Patients with the condi-
tions listed below are at high risk of stress-induced cardiac 
events; in such patients stress testing is contraindicated as 
a rule.
 1. Acute coronary syndrome within 48 h of onset.
 2. Poorly controlled heart failure/dyspnea.
 3. Poorly controlled hypertension.
 4. Symptomatic severe AS.3
 5. Severe obstructive hypertrophic cardiomyopathy 
(LVOT pressure gradient > 90 mmHg).
 6. Life-threatening arrhythmias.
 7. Acute phase of acute aortic dissection, aortic aneurysm 
with threatened rupture.
 8. Inability to exercise.4
 9. Without prior written consent to undergo the exercise 
stress testing.
 10. Any other patients who are identified as ineligible by 
their attending physicians.
Implementation of exercise stress testing
Before exercise stress testing
1. General precautions.
  Before stress testing, the clinical diagnosis, purpose of 
the test, medical history, and the patient’s current medi-
cations should be confirmed. Prior written consent must 
be obtained after an explanation of the specific stress 
testing method and possible side effects should be fully 
explained. Prior to implementation of exercise stress 
testing, the physician in charge must ask the patient’s 
clinical course including recent chest symptoms and the 
frequency of such symptoms. As a rule, a symptom-
limited exercise stress test (e.g., leg exhaustion, dysp-
nea, chest pain) should be performed. The patients are 
advised to wear comfortable pants and a patient’s gown 
for quick recording of echocardiograms.
2. Measurements of vital signs.
  If the patient suffers from tachycardia or presents 
blood pressure that differs from his/her normal level, its 
cause should be investigated and a decision should be 
made whether exercise stress testing may or may not be 
performed.
Fig. 1  Stress Echo Room (US Center, St. Marianna University School 
of Medicine). Exercise stress testing should be performed in a suffi-
ciently spacious room with the following equipment readily available: 
an emergency cart with emergency drugs and airway management 
devices, exercise stress monitoring system (automated sphygmoma-
nometer, 12-lead ECG monitor), defibrillator, and oxygen tanks
3 Exercise stress testing is contraindicated in patients with sympto-
matic severe AS. The patient diagnosed as asymptomatic at the time 
of appointment for the test may present with symptoms at the time of 
testing. It is imperative to reconfirm the absence of symptoms imme-
diately before testing. Pharmacological stress should be selected for 
patients incapable of performing exercise stress testing because of 
concomitant peripheral blood, orthopedic, or neurological disease. 
Patients incapable of understanding the explanation on giving consent 
to testing because of dementia or other reasons should be excluded 
from exercise stress echocardiography.
4 In treadmill exercise stress testing, patients may not be able to keep 
up with the machine’s walking speed. With elderly patients, due cau-
tion should be exercised to avoid the risk of falls, while ensuring that 
the treadmill belt velocities to be used are suitable for the patient and 
are reset if necessary before testing.
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3. To make it clear whether the patients correctly under-
stood the purpose of testing and procedure.
  It is indispensable to provide special care for patients 
undergoing the testing to relieve their anxieties.
4. To confirm the accuracy of echocardiographic images.
  You should confirm the chest areas where the trans-
ducer is to be properly placed to obtain ultrasound views 
and check that the chest ECG electrodes will not inter-
fere with the manipulation of the transducer.
Stress testing procedures
Treadmill exercise stress
1. Instruct the patient to stand on the belt and then com-
mence the stress test.
2. Increase the workload in a stepwise manner according 
to the Bruce protocol or another appropriate protocol. 
The Bruce protocol, which is originally intended to 
induce ischemia in patients with heart disease, gradu-
ally increases the workload in large increments. It should 
be noted that in the first step, the patient is required to 
walk at a rate of 1.7 miles/h (2.7 km/h) at a 10% incline, 
which is equivalent to a workload of approximately 
17–18 mL/min/kg body weight of oxygen consumption 
(approximately, 5 METS) for the elderly.
3. Monitor the patient’s ST-T changes and arrhythmias 
throughout exercise using an ultrasound monitor and 
measure blood pressure frequently.
4. Terminate exercise when the patient reaches the target 
heart rate or when any termination criterion is met; 
otherwise, continue up to the limit of tolerance of the 
patient.
5. Place the patient in the left lateral decubitus posi-
tion immediately after exercise and record post-stress 
echocardiograms.
6. To obtain better quality images, it is desirable that when-
ever it is possible, the images should be recorded while 
the patient is holding his/her breath, although it may be 
quite difficult for the patient to do so because of post-
exercise breathing difficulties.
7. It is desirable to complete echocardiographic recording 
within 2 min after the completion of exercise (Fig. 2).
8. For several minutes after the completion of treadmill 
exercise, the patient will experience breathing diffi-
culties, making clear imaging nearly impossible. The 
patient should be instructed in advance to exhale for 
as long as possible and inhale as briefly as possible 
immediately after the completion of exercise. The qual-
ity of ECGs can be improved by recording them dur-
ing prolonged expiration by the patient. The ultrasound 
images are generally observable during exhalation by 
the patient, but not during inhalation. Concentrate on 
recording during exhalation because it is important 
to collect good-quality images; there is little value in 
attempting to acquire quality images while the patient is 
inhaling. If they cannot obtain adequate images despite 
the above effort, the attending staff may instruct the 
patient to hold his/her breath briefly. Limit recording of 
each view to 10 s or less and obtain images in multiple 
views within a short interval. Struggling with one view 
that cannot be visualized will lead to losing all record-
ings in the other views. It is recommended to complete 
all image recordings within 2 min after exercise. You 
need to quickly complete the procedure to acquire high-
quality images that are adequate for the assessment, and 
this cannot be achieved without the patient’s co-opera-
tion.
Supine ergometer exercise stress
1. If the echo bed can be tilted laterally, place the patient 
in a slightly left lateral decubitus position and raise the 
upper portion so that the patient will assume a half-sit-
ting position.
2. Record resting echocardiography, blood pressure, and 
ECGs.
3. Instruct the patient to place his/her feet on the pedals and 
commence the exercise. The pedaling rate should be set 
at 50–60 revolutions/min.
4. The workload is generally increased by 25 W every 
3 min (Fig. 3a).
5. For the elderly with remarkable leg muscle weakness, 
a protocol using a 3-min warm-up at 10 W followed by 
10 W increments every 3 min may be used (Fig. 3b).
6. Monitor the patient’s ST-T changes and arrhythmias 
throughout exercise using an ultrasound monitor and 
record an ECG and blood pressure every minute.
Fig. 2  Exercise stress testing protocol (treadmill). The echocardio-
grams are obtained before and after the multistage stress test (Bruce 
protocol)
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7. Terminate the exercise when the patient reaches the tar-
get heart rate, or when any termination criterion is met; 
otherwise, continue up to the limit of tolerance of the 
patient.
8. In the supine ergometer exercise stress testing echocardi-
ography, echocardiographic assessment during exercise 
can be performed.
9. In the supine ergometer exercise stress testing, the 
images should be obtained with the patient placed in the 
left lateral decubitus position. Some of the authors expe-
rienced the following failures to acquire good-quality 
images at baseline; the improved data can be obtained 
once the test is commenced, i.e., after the patient starts 
pedaling with his/her feet on the pedals (with the feet 
raised). It is necessary to obtain data in the same views 
as those acquired at baseline. During the treadmill 
exercise testing, instruct the patient to exhale longer 
and inhale shorter than usual, and the operator should 
record as many images as possible during exhalation. In 
treadmill exercise echocardiography, image recording is 
commenced on completion of exercise after the patient 
is placed on the bed in a supine position. Stress-induced 
changes may resolve before being visualized unless 
imaging is done promptly; that is, image recording is 
under time constraints. On the other hand, in the supine 
ergometer exercise testing, the images can be recorded 
during exercise, which enables data collection over a 
longer period.
Fig. 3  Exercise stress protocol 
(ergometer). a Multistage proto-
col: the workload is increased at 
25-W increments every 3 min. b 
Ramp protocol: For the elderly 
with remarkable leg muscle 
weakness, a protocol with a 
3-min warm-up at 10 W, fol-
lowed by exercise with a 10-W 
increment every 3 min may be 
used. BP Blood pressure, HR 
heart rate, THR target heart rate
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Handgrip exercise stress
Handgrip exercise is an isometric exercise that imposes a 
pressure load primarily on the left ventricle. Increasing exer-
cise intensity markedly raises systolic pressure, while it only 
modestly affects heart rate. Numerous studies used a proto-
col with a 5-min sustained handgrip at 50% of the maximum 
voluntary contraction [31, 32]. Kerber et al. performed a 
handgrip exercise test and a treadmill exercise test in 90 
patients with coronary artery disease to evaluate the ability 
of these tests to detect ischemia. During the treadmill testing, 
ST segment depression was observed in 25 patients, in con-
trast with just 3 patients with sustained handgrip exercise. 
The heart rate–systolic pressure product was 223 (×102) for 
the former and small at 150 (×102) for the latter; diastolic 
pressure was 93 mmHg for the latter versus 81 mmHg for the 
former [33]. The difference between the two modalities of 
exercise may be explained by the insufficient increase myo-
cardial oxygen demand (less increase in heart rate) and the 
more coronary perfusion (due to increased diastolic blood 
pressure) in handgrip exercise. It was reported that the sen-
sitivity of adenosine stress increased with handgrip exercise 
[34] and that strain evaluation of pre- and post-handgrip 
exercise images was useful in the diagnosis of myocardial 
ischemia [35].
Hyperventilation
Hyperventilation (30 bpm) is sustained for 6 min to induce 
coronary artery spasm [36].
Leg raising
Cardiac preload can be increased with leg raising during 
echocardiographic assessment. The patient is positioned 
supine with the leg raised at approximately 45° with the 
support of a third person or an object (e.g., chair) placed 
under the feet [37, 38]. In healthy individuals, leg raising 
increases the SV with a slight change in blood pressure. As 
an alternative to leg raising, the leg positive pressure method 
is available, in which the patient’s legs are pressurized by 
inflating cuffs placed around the legs using an automated 
air pump [39, 40].
Stress test cessation criteria
Patient condition and blood pressure must be monitored 
while using ECG and during exercise. The test must be ter-
minated immediately in the event of a remarkable increase 
or decrease in blood pressure or significant arrhythmias and 
appropriate measures should be taken. The criteria for ter-
minating the testing based on the safety of patient are as 
follows:
1. Achievement of the target heart rate ([220 − patient’s 
age] × 0.85).
2. Excessive increase in blood pressure (systolic 
≥ 220 mmHg, diastolic ≥ 120 mmHg).
3. Decrease in blood pressure (fall of ≥ 10 mmHg during 
exercise or no increase with continued exercise).
4. Manifestation of sustained tachyarrhythmia.
5. Manifestation of akinesis-like decrease in the wall 
motion or of wall motion decrease over a broad range 
involving the territory of more than one coronary artery.
6. ST segment depression of ≥ 0.2 mV on ECG.
7. Development or exacerbation of chest pain.
8. Leg exhaustion.
9. Development of any other symptoms that make continu-
ation of exercise impossible.
What to assess
The assessments are made at rest, during exercise, and post-
exercise. Some parameters are unassessable during exer-
cise. Attempts should be made to assess such parameters 
as promptly as possible after exercise. For items assessed 
during exercise, there is no consensus regarding when to 
make an assessment. We usually start echocardiographic 
observation immediately after the initiation of exercise and 
continue monitoring until a change can be observed, as the 
workload is gradually increased.
1. ECG and blood pressure.
2. Echocardiographic assessment.
(a) In the parasternal long- and short-axis views (at 
the levels of the mitral valve, papillary muscles, 
and apex of the heart).
(b) In the apical 4-chamber, 2-chamber, and long-axis 
views.
(c) Of the LV inflow velocity patterns, mitral annular 
velocity patterns.
(d) IOf the LVOT velocity patterns.
(e) Of the tricuspid regurgitation (TR) velocity.
(f) Severity assessments for each valvular disease.
Precautions for implementation of exercise stress 
echocardiography
1. For the treadmill exercise testing, arrange the treadmill, 
a bed, and a compact echocardiographic system so that 
post-exercise imaging can be initiated as quickly as pos-
sible (Fig. 4).
2. Parasternal short-axis view, which contains the perfu-
sion territories of all three coronary arteries, is critical 
in the exercise stress echocardiographic assessment of 
the wall motion; yet, oblique sections can be a cause of 
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false-positive or false-negative results. An example: in 
the case of a long-axis view obtained by directing the 
beam through a lower intercostal space (Fig. 5a), the 
short-axis view gained by rotating this long-axis view 
by 90° results in an oblique section (Fig. 5b). In this 
section, the anteroseptal region is visualized close to 
the apex and the posterior wall more basally. Hence on 
visualizing the posterior wall, because of the influence 
of the mitral annulus, the inferior wall area may be mis-
interpreted as a site where there is decreased regional 
wall motion (arrow, Fig. 5c).
3. Exercise stress echocardiography is contraindicated in 
patients with unstable angina pectoris or symptomatic 
severe AS. The outpatient diagnosed as asymptomatic 
at the time of appointment for the test may possibly 
become symptomatic by the time of the test. It is impor-
tant to reconfirm the absence of symptoms immediately 
before starting the test.
4. The examiner should be careful not to concentrate exces-
sively on visualizing the structures, but to keep monitor-
ing the symptoms, blood pressure, heart rate, and ECG 
of the patient during exercise to minimize the risk of 
cardiac events.
5. In the supine ergometer testing, the patient may suddenly 
become unable to pedal because of leg exhaustion at 
the peak load. Instruct the patient to tell the examiner 
at the timing when the exercise is becoming too hard to 
continue before starting the peak load stage; the exam-
iner should start imaging slightly before the peak load 
stage. It is recommended, whenever possible, to moni-
tor the rate of perceived exertion using the Borg Scale 
or another appropriate rating scale. If the patient has 
become completely unable to pedal, assistance may be 
provided. (It is more practical to commence imaging 
immediately after ergometer exercise is started and to 
continue the exercise test while changes in parameters 
are monitored.)
6. Care should be taken to perform imaging in coordina-
tion with the patient’s breathing. Although it may be 
Fig. 4  Treadmill exercise testing room (Kindai University Hospital). 
The treadmill, bed, and echocardiographic system should be arranged 
as compact as possible
Fig. 5  An example of an oblique view. a A long-axis view obtained 
by directing the beam through a lower intercostal space; b a short-
axis view gained by rotating this long-axis view by 90°; c the result-
ing short-axis view is an oblique view with the anteroseptal region 
visualized close to the apex and the posterior wall more basally 
(arrow)
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difficult for the patient to hold a breath at peak load, 
attempts should be made to acquire the images while the 
patient is holding a breath whenever possible (forcing 
the patient to do so must be avoided). Regardless of such 
effort, images taken at peak load may not be of sufficient 
quality. Echocardiograms taken at a submaximal level 
(i.e., heart rate: approximately 100 bpm) may be used as 
a substitute for images at peak load.
7. The Images that can be obtained at peak load are limited. 
The examiner and the physician need to determine which 
images should be acquired at the peak load (e.g., trans-
mitral and transtricuspid regurgitant flow velocity pat-
terns, LVOT velocity patterns, images for wall motion 
assessment).
Exercise stress echocardiographic 
measurements for heart diseases
Ischemic heart disease
1. Wall motion.
  The assessment should be performed by reviewing the 
images at rest and exercise aligned side by side.
  The use of a 16-segment model of the left ventricle 
recommended by the American Society of Echocardi-
ography [41]. Evaluate semiquantitatively and score the 
wall motion of each segment (see the Ischemic Heart 
Disease Report [appendix]). Grade the wall motion 
as normokinesis, hypokinesis, akinesis, or dyskinesis. 
Using too many grades should be avoided since it will 
lead to greater interobserver variability and decreased 
assessment objectivity. The wall motion assessment 
should be based on not only left endocardial excursion, 
but also changes in the wall thickening. The data from 
the systolic wall motion alone should be examined so 
as not to be misled by the diastolic wall motion. Nor-
mally, exercise stress increases the systolic wall motion 
and left ventricular (LV) wall thickness. With stress, the 
absence of an increase in wall motion or wall thickening 
is assessed as abnormal. Exacerbation of wall motion 
of a normal or hypokinetic wall segment by one grade 
indicates a positive result for ischemia. The sufficient 
echocardiogram qualities facilitate diagnosis and con-
tribute to the diagnostic accuracy. Constant effort is 
required to achieve the best possible imaging quality, 
using optimal gain and slice plane selection.
Valvular heart disease
Mitral stenosis
Exercise stress echocardiography is employed in cases where 
resting echocardiographic data are not commensurate with 
the severity of symptoms, i.e., asymptomatic MS despite 
severe stenosis, or symptomatic MS despite mild to moder-
ate disease.
1. Transmitral pressure gradient.
  A mean pressure gradient is assessed based on mitral 
flow velocity at rest and exercise. An estimated mean 
pressure gradient of ≥ 15 mmHg during exercise indi-
cates severe MS [42].
2. Exercise-induced PH.
  Transtricuspid pressure gradient is assessed at rest and 
during exercise. An estimated systolic pulmonary artery 
pressure (PAP) of ≥ 60 mmHg during exercise indicates 
severe MS [42].
Mitral regurgitation
1. Severity of MR.
  Changes in MR are assessed quantitatively or semi-
quantitatively, comparing rest and exercise. It has been 
shown that worsening MR with exercise stress is associ-
ated with a poor prognosis [43]. The assessment of MR 
severity has been reported to be impossible in patients 
with heart rate ≥ 115 bpm [44].
2. Exercise-induced PH.
  Transtricuspid pressure gradient at rest and exercise is 
assessed. An estimated systolic pulmonary artery pres-
sure of ≥ 60 mmHg during exercise suggests exercise-
induced PH [45].
3. Contractile reserve.
  A decline in LV reserve (a change in LVEF during 
exercise ≤ 5% [46] or a change in the global longitudi-
nal strain ≤ 2% [47]) and reduction in right ventricular 
systolic function (tricuspid annular plane systolic excur-
sion < 18 mm [48]) have been reported to be predictors 
of a poor prognosis and of decreased cardiac function 
following mitral valve surgery.
Aortic stenosis
1. Aortic flow velocity and mean pressure gradient.
  Changes in the aortic flow velocity, mean pressure 
gradient, and CO (or pulsed Doppler time–velocity inte-
gral across the LVOT as a surrogate) are assessed, com-
paring at rest and exercise. A ≥ 18 mmHg increase in the 
mean pressure gradient at exercise has been reported to 
be associated with a poor prognosis, showing the useful-
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ness of this evaluation in risk stratification of asympto-
matic patients with AS [49].
2. Aortic valve area.
  The aortic valve area (AVA) is assessed under condi-
tions of increased CO with stress.
3. Exercise-induced PH.
  Transtricuspid pressure gradient is assessed at rest 
and during exercise. An estimated systolic PAP of 
≥ 60 mmHg during exercise suggests exercise-induced 
PH [50].
Aortic regurgitation (AR)
1. Contractile reserve.
  In patients with asymptomatic severe AR, reduced 
contractile reserve (increase in LVEF during exercise 
≤ 5%) has been reported to be a predictor of future car-
diac functional deterioration and of postoperative car-
diac function [51].
Cardiomyopathy
Dilated cardiomyopathy
1. Contractile reserve.
  Contractile reserve has been reported to well pre-
dict prognosis and beta blockers response in dilated 
cardiomyopathy. The stress protocols and assessment 
methods vary from study to study. Contractile reserve 
can be assessed based on low-dose (10–20 μg/kg/min) 
dobutamine-induced changes in LVEF [52], LV volume 
[53], and strain [54] from the resting state.
2. Functional MR.
  Functional MR at rest and exercise is assessed visu-
ally, or if possible, quantitatively. An increase in func-
tional MR with stress (effective regurgitant orifice 
≥ 13 mm2) has been reported to predict a poor prognosis 
[55].
3. Exercise-induced PH.
  Transtricuspid pressure gradient is assessed at rest 
and exercise. An increase in estimated systolic PAP of 
≥ 60 mmHg with exercise has been reported to indicate 
a poor prognosis [56].
4. Prediction of cardiac resynchronization therapy (CRT).
  LVEF response to low-dose dobutamine infusion 
(10 μg/kg/min, LVEF ≥ 7.5%) has been reported to be 
useful in the prediction of responders to CRT [57].
Hypertrophic cardiomyopathy
1. LVOT obstruction.
  LVOT obstruction may appear at exercise, but not at 
rest in some patients (exercise-induced LVOT obstruc-
tion; maximum LVOT gradient ≥ 50 mmHg). Exercise 
stress echocardiography is indicated in the diagnosis of 
such patients [58].
2. Wall motion assessment.
  Patients without significant coronary stenosis may 
have relative subendocardial ischemia in the hyper-
trophic myocardium, and in such patients wall motion 
abnormalities may be induced by exercise stress. LV 
wall motion abnormalities with exercise have been 
reported to indicate a poor prognosis in hypertrophic 
cardiomyopathy [59].
3. MR.
  Changes in MR that are associated with systolic ante-
rior motion of the mitral valve are also assessed [60].
4. Exercise-induced PH.
  Exercise-induced PH, which is often a complication 
of LV diastolic dysfunction, is assessed [61].
Ph
1. Exercise-induced PH.
  Transtricuspid pressure gradient at rest and exercise is 
assessed. An estimated systolic PAP of ≥ 40–50 mmHg, 
depending on the exercise stress testing method used, 
indicating exercise-induced PH [62].
2. CO.
  Since PAP depends on CO, CO is evaluated at rest and 
exercise. An increase by 3.0 mmHg/L/min in mean PAP 
(mPAP) as a function of CO (∆mPAP/∆CO) in healthy 
subjects has been reported [63].5
Dobutamine stress echocardiography (for 
reference)
Introduction
Currently, dobutamine echocardiography is not covered by 
the national health insurance in Japan, whereas in actual 
clinical settings there are numerous patients, including the 
elderly, who are unable to perform exercise stress testing 
and for whom pharmacological stress echocardiography is 
deemed necessary. In addition, for diagnosis of ischemic 
heart disease (IHD), pharmacological stress echocardiog-
raphy is less costly than radionuclide scanning and can be 
conducted, unlike contrast-enhanced computed tomography 
or magnetic resonance imaging, in patients with renal dys-
function, bronchial asthma, or hypersensitivity to contrast 
media. Although this guideline focuses on exercise stress 
5 mPAP was estimated as mPAP = 0.6 × estimated systolic PAP + 2 
(mmHg) [64].
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echocardiography, dobutamine stress echocardiography is 
also described herein for reference, considering the clinical 
utility of this modality.
Objectives of dobutamine stress echocardiography
A considerable number of elderly patients and patients with 
orthopedic or neurological disease are unable to perform 
exercise stress testing of sufficient intensity. In such cases, 
dobutamine echocardiography is indicated. This modality, 
which permits stable tomographic image recording dur-
ing stress, allows for more detailed assessment of LV wall 
motion, compared with exercise stress echocardiography. 
Dobutamine stress echocardiography is useful not only in 
the evaluation of myocardial ischemia, but also in the assess-
ment of myocardial viability and contractile reserve in peo-
ple following myocardial infarction or those with chronic 
IHD. Furthermore, in distinguishing true, severe AS from 
‘pseudo-severe’ AS in those with low-flow, low-gradient 
severe AS with reduced LVEF.
Safety of dobutamine stress echocardiography
The most commonly reported complications of dobutamine 
stress echocardiography include decreased blood pressure 
(1.7%), supraventricular tachycardia (1.3%), increased blood 
pressure (1.3%), atrial fibrillation (0.9%), atrioventricular 
block (0.23%), ventricular tachycardia (0.15%), coronary 
artery spasm (0.14%), ventricular fibrillation (0.04%), 
myocardial infarction (0.02%), cerebrovascular disorder 
(0.005%), and cardiac rupture (0.002%) [65, 66]. In per-
forming dobutamine stress echocardiography, we recom-
mend equipping the testing room with an emergency cart 
with supplies ready for use, to enable the attending staff 
to take necessary measures promptly when any of these 
complications occur. Palpitations, sensation of warmth, and 
voiding sensation are relatively frequently observed, but 
rapidly subside when dobutamine infusion is terminated. If 
any of these symptoms develop during testing, the attend-
ing staff should explain this to the patient and continue the 
test providing the event is deemed to be tolerable. Other 
possible complications include bradycardia and a decline 
in blood pressure due to vagal reflexes; in the event of these 
complications, if discussion or handgrip exercise does not 
improve the situation, atropine should be administered. In 
addition, it is recommended to keep the patient at rest and 
observe his/her clinical course for at least 30 min post-stress.
Implementation of dobutamine stress 
echocardiography
Dobutamine infusion in patients with IHD should be initi-
ated at 5 μg/kg/min, with an increment to 10, 20, 30, and 
40 μg/kg/min at 5-min intervals. In cases where dobutamine 
doses up to 40 μg/kg/min neither achieve the target heart 
rate nor meet any cessation criterion, the dose should be 
increased to 50 μg/kg/min, or 0.25 mg of atropine should be 
administered every minute up to 2 mg at maximum. It is also 
helpful to add a handgrip exercise stress. Low-dose dobu-
tamine stress testing for assessment of myocardial viability 
or AS should be initiated at 5 μg/kg/min, with a 5-μg incre-
ment every 5 min to 10, 15, and 20 μg/kg/min.
Criteria for dobutamine stress test termination include 
the following:
1. The target heart rate of (220 − age) × 0.85 (bpm) has 
been reached.
2. A significant decrease in blood pressure (sys-
tolic: ≤ 80 mmHg) or significant increase (systolic: 
≥ 220 mmHg).
3. Manifestation of a significant tachyarrhythmia.
4. Manifestation of intolerable chest pain, nausea, head-
ache, urge to void, etc.
5. Manifestation of severe myocardial ischemia, such as 
a new akinesis-like decrease in wall motion and dete-
riorating wall motion over a broad area involving the 
territory of more than one coronary artery.
6. ST segment depression of ≥ 0.2 mV on ECG.
Dobutamine echocardiographic measurements 
for heart diseases
Ischemic heart disease
Wall motion As in the case of exercise stress echocardiog-
raphy, wall motion is graded as normokinesis, hypokinesis, 
akinesis, or dyskinesis. Responses to dobutamine stress are 
categorized into the following four types: (1) improvement: 
wall motion improves with low-dose dobutamine as well as 
with high doses; (2) biphasic: wall motion improves with 
low-dose dobutamine but worsens with high doses; (3) 
worsening: wall motion decreases with low-dose stress and 
worsens with high doses; and (4) fixed: wall motion remains 
unchanged with dobutamine stress. Improvement indicates 
myocardial viability without ischemia. The biphasic or wors-
ening responses are seen in the presence of both myocardial 
viability and ischemia. The fixed type, where wall motion 
remains akinetic during low- and high-dose dobutamine 
stress, indicates a lack of myocardial viability.
AS
The peak velocity and pressure gradient of aortic flow 
depend on the flow rate, i.e., the volume of blood that 
flows past the aortic orifice per unit time. The flow rate 
is obtained from stroke volume (SV) divided by ejection 
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time. Generally, an indexed SV (SV divided by the body 
surface area) < 35 mL/m2 is defined as ‘low flow,’ and a 
mean aortic pressure gradient < 40 mmHg as ‘low gradient’. 
Low-flow, low-gradient severe AS despite the aortic valve 
area (AVA) satisfying the diagnostic criteria for severe AS 
suggests either decreased LVEF or decreased stroke volume 
due to small LV end-diastolic volume with normal LVEF in 
the absence of significant MR. The former is referred to as 
classical low-flow low-gradient severe AS, and the latter as 
paradoxical low-flow low-gradient severe AS.
Classical low-flow low-gradient severe AS can be divided into 
two clinical states: true, severe AS and ‘pseudo-severe’ AS, where 
complete opening of the aortic valve is hindered, despite AS of 
intermediate or mild intensity, by decreased LVEF. Dobutamine 
echography is useful in differentiating between these two states.
In other words, where complete valve opening appears 
to occur with increased CO, this is diagnosed as ‘pseudo-
severe’ AS.
Cases showing an insufficient (< 20%) SV increase with 
dobutamine stress are considered to lack LV contractile reserve, 
and in these circumstances, differentiation between true and 
pseudo-severe AS is impossible. Patients lacking LV contractile 
reserve have been reported to be at higher risk of operational 
death compared to those with reserve, but to be associated with 
a better prognosis following aortic valve replacement surgery 
than with medical treatment [68]. In addition to the above 
semiquantitative assessment method, a method based on the 
projected AVA [69] is available. AVA  (cm2) is plotted against 
flow rate (mL/s) at four stages (at rest and with dobutamine 
stress at 5, 10, and 20 μg/kg/min) to generate a linear regres-
sion formula, and using this formula the AVA at a flow rate of 
250 mL/s is calculated as the projected AVA. AS is diagnosed 
as truly severe if the projected AVA is less than 1.0 cm2 (Fig. 6).
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Fig. 6  Calculation of the projected AVA. AVA  (cm2) is plotted 
against flow rate (mL/s) at four stages (at rest and with dobutamine 
stress at 5, 10, and 20 μg/kg/min) to generate a linear regression for-
mula. The AVA at flow rate of 250  mL/s is obtained from this for-
mula as the projected AVA. If this value is < 1.0 cm2, true severe AS 
is diagnosed
True, severe AS is defined by an AVA ≤ 1.0 cm2 with a 
peak aortic valve velocity ≥ 4.0 m/s and a mean aortic valve 
gradient  40 mmHg [67].
Pibarot et al. [68]. define ‘true severe AS’ using the fol-
lowing criteria, in addition to ≥ 20% increase in SV with 
20 μg/kg/min dobutamine infusion; all other AS cases are 
considered ‘pseudo-severe.’
1. An increase in mean pressure gradient to > 30 mmHg.
2. Peak-stress effective orifice area ≤ 1.0 cm2 or < 1.2 cm2, 
depending on testing conditions.
3. An increase in effective orifice area of < 0.3 cm2.
Explanation and Consent Form for Stress Echocardiography
ID number Name
Date of birth
Why we need to test your heart
Stress echocardiography by putting stress on your heart is 
required to uncover hidden conditions that are not detect-
able with resting echocardiography, to allow more detailed 
assessment of how sick you are.
Objectives of testing
The objectives differ depending on the type of heart disease 
you have.
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1. Coronary artery disease To see whether left ventricu-
lar wall motion abnormalities appear with stress and to 
assess whether blood supply from the arteries of the 
heart to the heart muscle is sufficient.
2. Valvular heart disease To diagnose how heart function 
changes during exercise and to decide whether surgery 
is necessary or not.
3. Cardiomyopathy To detect heart reserve and changes in 
blood flow during exercise, and to select medications 
and treatment of the condition
Testing methods
We put stress on the heart using either exercise or drug stim-
ulation. For exercise stress testing, the various methods are 
shown below. Electrocardiograms (ECGs) will be obtained 
before stress and during or after stress. A cardiologist will 
be present during the tests to ensure your safety and moni-
tor your clinical condition. Your ECGs and blood pressure 
will be recorded. In the testing room, emergency equipment 
and drugs are readily available for the staff to provide urgent 
measures when any undesirable event occurs.
• Exercise stress echocardiography.
  – Treadmill.
– Cycle ergometer (sitting, lying).
– Handgrip.
– Six-minute walk.
– Master step test.
• Pharmacological (dobutamine) stress echocardiography.
Explanation of each method
Treadmill exercise stress test
You will be asked to walk on a moving belt, which looks like 
a conveyor belt, at a speed set by the machine. The grade and 
speed will gradually be increased every 2–3 min. A cardiolo-
gist will be supervising the test for your safety and from time 
to time may ask you how you are feeling. Your ECG and 
blood pressure will be monitored and recorded during the 
test. The test will be stopped if your heart rate has reached 
the target level, or if you no longer feel able to exercise 
because of breathlessness, chest pain, or any other reason, or 
if any abnormality is found on your ECG. Echocardiography 
will be performed before and after exercise.
Ergometer stress test
You will be asked to pedal in a sitting or lying position at 
a constant rate. The pedaling rate suitable for you will be 
determined for the test. The resistance you will feel will be 
mild in the beginning and will increase gradually, but you 
are asked to continue pedaling at the same rate. A cardiolo-
gist will supervise the test for your safety and from time to 
time may ask you how you are feeling. Your ECG and blood 
pressure will be monitored and recorded during the test. The 
test will be stopped if your heart rate has reached the tar-
get level, or if you no longer feel able to exercise because 
of breathlessness, chest pain, or any other reason, or if any 
abnormality is found on your ECG. Echocardiography will 
be performed before and and during after exercise.
Handgrip exercise stress test
You will be asked to continue grasping a handgrip for 
4–5 min at about half of your maximum grip strength. If 
you notice any symptoms during the exercise, please let the 
attending staffs know. If you no longer feel able to continue 
the exercise, the test will be stopped at that point. Echo-
cardiography will be performed before, and during or after 
exercise.
Six‑minute walk test
You will be asked to walk for 6 min at your own pace on a 
predetermined course with an attending examiner, who will 
check on you if you are short of breath or have chest pain 
along the way. Echocardiography will be performed before 
and after exercise.
Master step test
This is an exercise test where you step up and down, and 
continue this for either ninety seconds or three minutes, as 
predetermined by a cardiologist. The number of steps to be 
used depends on your age and gender. You will be instructed 
to step up and down the Master step. The test will be stopped 
if you no longer feel able to continue the exercise because of 
breathlessness or chest pain, or if any abnormality is noted 
on your ECG. Echocardiography will be performed before 
and after exercise.
Pharmacological (dobutamine) stress echocardiography
This is a test to diagnose your heart reserve by imposing 
stress on your heart with drug infusion. Dobutamine (a drug 
that stimulates the heart muscle) is used. Symptoms such 
as a rapid heartbeat and flushing of the face are expected to 
occur but will disappear within 10 min after the end of the 
infusion.
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Risks, complications, and side effects
There are small risks associated with exercise stress echo-
cardiography. Specifically, these risks include lowering 
or raising of blood pressure, dizziness, an irregular pulse, 
fainting, and chest discomfort. Stress imposed on the heart 
for diagnostic purposes may cause lengthy angina pain, or 
even myocardial infarction or arrhythmias but serious com-
plications are rare. In the event of a side effect, emergency 
measures including urgent hospitalization may be required 
(urgent hospitalization is needed in one in about 43,000 
tests; death can occur once in about 264,000 tests [source: 
Japanese Society of Electrocardiography])—medical costs 
will then need to be borne by the patient, as is usually the 
case with our healthcare services. During treadmill stress 
testing, a fall and resulting bone fracture may occur. If the 
patient’s legs have become very tired during the exercise, 
the examiner may stop the machine right away to prevent 
accidents such as falling off the treadmill.
Pharmacological stress testing is also reported to be asso-
ciated with complications, as is the case with exercise stress 
testing. Stress testing with drug stimulation is not necessar-
ily safer.
Being a test that imposes stress on the heart, stress echo-
cardiography might result in the development of heart attack 
or arrhythmias, or very rarely, death. Rates of occurrence of 
emergency hospitalization or serious but non-fatal compli-
cations such as myocardial infarction are estimated at 0.2% 
or less.
I have received an explanation of the testing described 
above and satisfactory answers to the questions I have asked; 
I agree to engage in a stress test.
(I understand that this consent can be withdrawn at any 
time.)
Date of consent: 
Patient or proxy (Relationship with the patient )
Signature
Parent/guardian of minor patient (Relationship with the patient )
Signature
(Relationship with the patient )
Signature
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Exercise Stress Echocardiography Report
Paent ID
Paent name
Date of birth
Gender Age
Height cm Weight kg
Referring 
department
Referring 
physician
Outpaent Inpaent Ward
Date of test
Test number
Equipment used
Test performed 
by
Technologist:
Physician:
Clinical diagnosis ( )
Objecve of the 
test
Ischemic heart disease workup
Cardiomyopathy workup (DCM / HCM / other )
Valvular heart disease workup (AS / AR / MS / MR / other )
Pulmonary hypertension workup
Other ( )
Coronary risk 
factors
ٸHypertension   ٸ Diabetes mellitus   ٸ Hyperlipidemia ٸ Smoking ٸ Other ( )
Underlying disease 
informaon 
ٸOld myocardial infarcon   ٸ Chronic heart failure   ٸCKD   ٸ COPDٸAtrial fibrillaon   ٸ Pacing   ٸ Post AVR / MVR ٸ Post CABG
Medicaon ٸBeta blocker (                               /                mg)ٸConnued / withheld for 24 h / withheld for 48 hٸ ACE-I/ARB ٸ Calcium antagonist   ٸ Anplatelet drug   ٸ Other ( )
Special instrucon ( )
Post exercise %THR             %   
Test goal achievement (Achieved  / Not achieved/Insufficient workload)
Cause of test 
cessaon
Leg exhauson / Dyspnea / Ischemic changes
Target heart rate reached (%THR            %) / Events
Adverse events ٸNone   ٸ Chest pain (Nitroglycerin given / not given)ٸ ST-T change ( )ٸ Arrhythmias (PVC / PAF / NSVT / VT / )ٸ Vagal reflex   ٸ Fall/trauma   ٸ Other ( )
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Time started :
Stage SBP / DBP HR ST change
Arrhyth-
mias Symptoms
Pre
Cumu-
lave
me 
(min)
/
Stage 1
1 /
2 /
3 /
Stage 2
4 /
5 /
6 /
Stage 3
7 /
8 /
9 /
Stage 4
10 /
11 /
12 /
Post
Exercise
1 /
2 /
3 /
4 /
5 /
Treadmill Exercise Stress Test Data Record (Bruce Protocol)
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Time started :
Stage SBP(mmHg) / DBP(mmHg) HR(bpM mm)
ST 
change
Arrhyth-
mias Symptoms
Pre
Cumu-
lave
me 
(min)
/
Exercise
25wa
1 /
2 /
3 /
Exercise
50wa
4 /
5 /
6 /
Exercise
75wa
7 /
8 /
9 /
Exercise
100wa
10 /
11 /
12 /
Exercise
125wa
13 /
14 /
15 /
Exercise
150wa
16 /
17 /
18 /
Post
Exercise
1 /
2 /
3 /
4 /
5 /
Ergometer Mulstep Exercise Stress Test Data Record
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Time started :
Stage SBP
(mmHg)
/ DBP
(mmHg)
HR
(bpm)
ST 
change
Arrhyth-
mias Symptoms
Pre
Cumu-
lave
me 
(min)
/
Exercise
25 W
1 /
2 /
3 /
Exercise
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4 /
5 /
6 /
Exercise
75 W
7 /
8 /
9 /
Exercise
100 W
10 /
11 /
12 /
Exercise
125 W
13 /
14 /
15 /
Exercise
150 W
16 /
17 /
18 /
Post
Exercise
1 /
2 /
3 /
4 /
5 /
Ergometer Mulstage Exercise Stress Test Data Record
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Left cardiac system standard measurements
Rest Sub maximal Peak Post Ex
Heart rate /min /min /min /min
LAD mm mm mm mm
LVDd mm mm mm mm
LVDd index mm/m2 mm/m2 mm/m2 mm/m2
LVDs mm mm mm mm
LVDs index mm/m2 mm/m2 mm/m2 mm/m2
%FS % % % %
LA volume index ml/m2 ml/m2 ml/m2 ml/m2
LVEDV biplane ml ml ml ml
LVESV biplane ml ml ml ml
SV bipalne ml ml ml ml
EF biplane % % % %
Doppler measurements
Rest Sub maximal Peak Post Ex
Heart rate /min /min /min /min
E wavw velocity cm/s cm/s cm/s cm/s
DcT ms ms ms ms
E/A
 E′ sep cm/s cm/s cm/s cm/s
 S′ sep cm/s cm/s cm/s cm/s
 E′ lat cm/s cm/s cm/s cm/s
 S′ lat cm/s cm/s cm/s cm/s
 E′ average cm/s cm/s cm/s cm/s
 E/E′ averege
Right cardiac system standard measurements
Rest Sub maximal Peak Post Ex
Heart rate /min /min /min /min
RV EDA cm2 cm2 cm2 cm2
RV ESA cm2 cm2 cm2 cm2
FAC % % % %
E′ RV cm/s cm/s cm/s cm/s
S′ RV cm/s cm/s cm/s cm/s
TAPSE mm mm mm mm
TRPG mmHg mmHg mmHg mmHg
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Ischemic Heart Disease Report
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Stress Echocardiographic Wall Moon Assessment Data Record
Wall moon Score
Poorly imaged ¼
Normal ڭ
Hypokinec ڮ
Akinec گ
Dyskinec ڰ
Pre-stress
During stress
Post-stress
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Valvular heart disease report
MS Rest Sub maximal Peak Post Ex
HR bpm bpm bpm bpm
MV area CW cm2 cm2 cm2 cm2
Peak velocity cm/s cm/s cm/s cm/s
Max PG mmHG mmHG mmHG mmHG
Mean PG mmHG mmHG mmHG mmHG
PHT ms ms ms ms
MR Rest Sub maximal Peak Post Ex
MR RV (volumetric) ml ml ml ml
MR RF % % % %
MR ERO (volumetric) cm2 cm2 cm2 cm2
MR RV (PISA) ml ml ml ml
MR ERO (PISA) cm2 cm2 cm2 cm2
Vena contracta mm mm mm mm
PHT ms ms ms ms
AS Rest Sub maximal Peak Post Ex
AVA cm2 cm2 cm2 cm2
AVAi cm2/m2 cm2/m2 cm2/m2 cm2/m2
VTI AV cm cm cm cm
VTI ration (AV/LVOT)
HR /min /min /min /min
Ejection time ms ms ms ms
Peak velocity cm/s cm/s cm/s cm/s
Mean PG mmHG mmHG mmHG mmHG
AR Rest Sub maximal Peak Post Ex
AR RV (volumetric) ml ml ml ml
AR RF % % % %
AR ERO (volumetric) cm2 cm2 cm2 cm2
AR RV (PISA) ml ml ml ml
AR ERO (PISA) cm2 cm2 cm2 cm2
Vena contracta mm mm mm mm
PHT ms ms ms ms
Pulmonary hypertension report
Rest Sub maximal Peak Post Ex
BP mmHG mmHG mmHG mmHG
HR /min /min /min /min
TR peak velocity cm/s cm/s cm/s cm/s
TRPG mmHG mmHG mmHG mmHG
RVSP mmHG mmHG mmHG mmHG
LVOT diameter mm
LVOT TVI cm cm cm cm
HR /min /min /min /min
Cardiac output l/min l/min l/min l/min
Stroke volume ml ml ml ml
RVOT diameter mm mm mm mm
Rest Sub maximal Peak Post Ex
RVOT TVI cm cm cm cm
HR /min /min /min /min
RV cardiac output l/min l/min l/min l/min
RV stroke volume l/min/m2 l/min/m2 l/min/m2 l/min/m2
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